FRIDAY, April 27 (HealthDay News) -- Votrient (pazopanib) has been approved by the U.S. Food and Drug Administration to treat people with soft tissue sarcoma that have received previous chemotherapy.
Source: http://health.yahoo.net/news/s/hsn/votrient-approved-to-treat-cancer-that-begins-in-soft-tissue
Libya Pia Toscano Rachel Zoe Christina
No comments:
Post a Comment
Note: only a member of this blog may post a comment.